1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow ex vivo-expanded HER2-specific T cells: new trials by email Literature Review of ex vivo-expanded HER2-specific T cells trials Research Report on ex vivo-expanded HER2-specific T cells
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vaccine Therapy in Treating Patients With Stage IV Breast Cancer HER-2/neu peptide vaccine, leukapheresis, ex vivo-expanded HER2-specific T cells - HER2-positive Breast Cancer, Male Breast Cancer | Phase 1 / Phase 2 | Completed | University of Washington | 23 | 2008-10-01 | 2017-05-25 |
Breast Neoplasms (1) · Breast Neoplasms, Male (1)
United States (1)
Mary Disis (1)
R01CA129517 (1)